Evidence map›Paper›PMID 42332738›Full record

ArticleAnnals of clinical microbiology and antimicrobials2026

Convergent evolution of ST2 and ST164 mediates dissemination of the bla

Ren Liu, Guilin Jin, Feng Yu, Hui Tan, Fang Yuan, Peiwen Zhang, Yinyi Chen, Liang Xiao, Xiaojun Yang

Abstract read
In one paragraph

Article in Annals of clinical microbiology and antimicrobials, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Ren Liu *Department of Clinical Laboratory, The Affiliated Hospital of Jiangxi University of Chinese Medicine, Jiangxi University of Chinese Medicine, 445 Bayi Avenue, Nanchang, 330006, Jiangxi, People's Republic of China.ORCID http://orcid.org/0000-0001-8967-130X
Guilin Jin *Department of Clinical Laboratory, The Affiliated Hospital of Jiangxi University of Chinese Medicine, Jiangxi University of Chinese Medicine, 445 Bayi Avenue, Nanchang, 330006, Jiangxi, People's Republic of China.
Feng Yu *Department of Clinical Laboratory, The Affiliated Hospital of Jiangxi University of Chinese Medicine, Jiangxi University of Chinese Medicine, 445 Bayi Avenue, Nanchang, 330006, Jiangxi, People's Republic of China.
Hui TanDepartment of Clinical Laboratory, The Affiliated Hospital of Jiangxi University of Chinese Medicine, Jiangxi University of Chinese Medicine, 445 Bayi Avenue, Nanchang, 330006, Jiangxi, People's Republic of China.
Fang YuanDepartment of Clinical Laboratory, The Affiliated Hospital of Jiangxi University of Chinese Medicine, Jiangxi University of Chinese Medicine, 445 Bayi Avenue, Nanchang, 330006, Jiangxi, People's Republic of China.
Peiwen ZhangDepartment of Clinical Laboratory, The Affiliated Hospital of Jiangxi University of Chinese Medicine, Jiangxi University of Chinese Medicine, 445 Bayi Avenue, Nanchang, 330006, Jiangxi, People's Republic of China.
Yinyi ChenDepartment of Clinical Laboratory, The Affiliated Hospital of Jiangxi University of Chinese Medicine, Jiangxi University of Chinese Medicine, 445 Bayi Avenue, Nanchang, 330006, Jiangxi, People's Republic of China.
Liang XiaoDepartment of Clinical Laboratory, The Affiliated Hospital of Jiangxi University of Chinese Medicine, Jiangxi University of Chinese Medicine, 445 Bayi Avenue, Nanchang, 330006, Jiangxi, People's Republic of China. xiaoliang@jxutcm.edu.cn.
Xiaojun YangDepartment of Clinical Laboratory, The Affiliated Hospital of Jiangxi University of Chinese Medicine, Jiangxi University of Chinese Medicine, 445 Bayi Avenue, Nanchang, 330006, Jiangxi, People's Republic of China. yangxiaojun@jxutcm.edu.cn.

Funding

Science and Technology Project of Jiangxi Provincial Health Commission 2022B932
6 · The paper itself

Abstract

backgroundThe convergence of the potent carbapenemase genes bla

methodsWe performed a comprehensive genomic analysis of a global collection of 1820 high-quality public WGS-derived CRAB isolates (2001-2024) harbouring acquired non-OXA carbapenemase genes. Topological congruence between bla

resultsCo-occurring acquired carbapenemase genes dominated the cohort, with the combination of bla

conclusionsThe widespread dissemination of the bla

Indexed as

Acinetobacter baumanniiBacterial Proteinsbeta-LactamasesEvolution, MolecularAcinetobacter InfectionsAnti-Bacterial AgentsCarbapenemsDrug Resistance, Multiple, BacterialGenome-Wide Association StudyHumansMicrobial Sensitivity TestsPhylogenyAnti-Bacterial AgentsBacterial Proteinsbeta-lactamase NDM-1beta-LactamasescarbapenemaseCarbapenemsAcinetobacter baumanniiBla NDM-1Bla OXA-23Clonal expansionPhylogenomics

Identifiers

PMID42332738
PMCPMC13584254

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.